1-3 of 3
Stefanie Hayoz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma

Clinical Trials & Observations
Anastasios Stathis, Ulrich Mey, Sämi Schär, Felicitas Hitz, Christiane Pott, Nicolas Mach, Fatime Krasniqi, Urban Novak, Christian Schmidt, Karin Hohloch, Dirk Lars Kienle, Dagmar Hess, Alden A. Moccia, Michael Unterhalt, Katrin Eckhardt, Stefanie Hayoz, Gabriela Forestieri, Davide Rossi, Stefan Dirnhofer, Luca Ceriani, Giulio Sartori, Francesco Bertoni, Christian Buske, Emanuele Zucca, Wolfgang Hiddemann
Journal: Blood Advances
Blood Adv (2022) 6 (13): 3911–3920.
https://doi.org/10.1182/bloodadvances.2021006520
Published: 2022
Includes: Supplemental data
Journal Articles

Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial

Clinical Trials & Observations
Alden A. Moccia, Christian Taverna, Sämi Schär, Anna Vanazzi, Stéphanie Rondeau, Felicitas Hitz, Walter Mingrone, Thomas Pabst, Lidija Cevreska, Auro del Giglio, Johann Raats, Daniel Rauch, Daniel A. Vorobiof, Andreas Lohri, Céline Ruegsegger, Christine Biaggi Rudolf, Corinne Rusterholz, Stefanie Hayoz, Michele Ghielmini, Emanuele Zucca
Journal: Blood Advances
Blood Adv (2020) 4 (23): 5951–5957.
https://doi.org/10.1182/bloodadvances.2020002858
Published: 2020
Journal Articles

SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model

Clinical Trials & Observations
Luca Ceriani, Giuseppe Gritti, Luciano Cascione, Maria Cristina Pirosa, Angela Polino, Teresa Ruberto, Anastasios Stathis, Andrea Bruno, Alden A. Moccia, Luca Giovanella, Stefanie Hayoz, Sämi Schär, Stefan Dirnhofer, Alessandro Rambaldi, Giovanni Martinelli, Christoph Mamot, Emanuele Zucca
Journal: Blood Advances
Blood Adv (2020) 4 (6): 1082–1092.
https://doi.org/10.1182/bloodadvances.2019001201
Published: 2020